Concepedia

Adam L. Meyers

AL

Statistics

Publications

15

Citations

736

H-Index

15

Active since

2005

Affiliations

Eli Lilly (United States)(Current)

Biogen (United States)

University of Pennsylvania

Harvard University

Adam L. Meyers is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and pharmacotherapy.

Top concepts

Publications per year

2005–2025

15

Publications

15

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

Merit Cudkowicz, Leonard H. van den Berg, Jeremy M. Shefner et al. · The Lancet Neurology · 2013 · 232 citations

, , +6

Differential Efficacy of Olanzapine and Lithium in Preventing Manic or Mixed Recurrence in Patients With Bipolar I Disorder Based on Number of Previous Manic or Mixed Episodes

Terence A. Ketter, John P. Houston, David Adams et al. · The Journal of Clinical Psychiatry · 2006 · 85 citations

Reduced Suicidal Ideation in Bipolar I Disorder Mixed-Episode Patients in a Placebo-Controlled Trial of Olanzapine Combined With Lithium or Divalproex

John P. Houston, Jonna Ahl, Adam L. Meyers et al. · The Journal of Clinical Psychiatry · 2006 · 52 citations

Wellness Intervention for Patients With Serious and Persistent Mental Illness

Vicki Poole Hoffmann, Jonna Ahl, Adam L. Meyers et al. · The Journal of Clinical Psychiatry · 2005 · 46 citations

Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia

John Kennedy, Walter Deberdt, Alan P. Siegal et al. · International Journal of Geriatric Psychiatry · 2005 · 42 citations

Rows per page

1–5 of 15